Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trouw

Showing results (271-280 of 283) with videos related to

Pageof 29
Sort By:
Molecular Immunology|March 18, 2020
Expression and production of the SERPING1-encoded endogenous complement regulator C1-inhibitor in multiple cohorts of tuberculosis patientsRosalie Lubbers, Jayne S Sutherland, Delia Goletti, et al.
Arthritis Research & Therapy|December 2, 2016
Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort studyTineke J van Wesemael, Sofia Ajeganova, Jennifer Humphreys, et al.
Annals of the Rheumatic Diseases|January 15, 2015
Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritisYoann Rombouts, Annemiek Willemze, Joyce J B C van Beers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2018
Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk IndividualsMarije K Verheul, Stefan Böhringer, Myrthe A M van Delft, et al.
The Review of Scientific Instruments|February 3, 2017
Inverse-collimated proton radiography for imaging thin materialsMatthew S Freeman, Jason Allison, Malcolm Andrews, et al.
Frontiers in Immunology|November 9, 2018
Complement Component C1q as Serum Biomarker to Detect Active TuberculosisRosalie Lubbers, Jayne S Sutherland, Delia Goletti, et al.
International Journal of Molecular Sciences|July 2, 2021
Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational StudyThijs W de Vos, Dian Winkelhorst, Hans J Baelde, et al.
Journal of Autoimmunity|June 30, 2015
Marked variability in clinical presentation and outcome of patients with C1q immunodeficiencyRosanne A van Schaarenburg, Lone Schejbel, Lennart Truedsson, et al.
Modern Rheumatology|April 15, 2021
Anti-carbamylated protein antibodies positivity and disease activity in Hispanic patients with established rheumatoid arthritis: An observational studyDavid Vega-Morales, Mario A Garza-Elizondo, Leendert A Trouw, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 31, 2020
HLA-B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid ArthritisCristina Regueiro, Desire Casares-Marfil, Karin Lundberg, et al.
Pageof 29

Showing results (271-280 of 283) with videos related to

Sort By:
Pageof 29
Molecular Immunology|March 18, 2020
Expression and production of the SERPING1-encoded endogenous complement regulator C1-inhibitor in multiple cohorts of tuberculosis patientsRosalie Lubbers, Jayne S Sutherland, Delia Goletti, et al.
Arthritis Research & Therapy|December 2, 2016
Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort studyTineke J van Wesemael, Sofia Ajeganova, Jennifer Humphreys, et al.
Annals of the Rheumatic Diseases|January 15, 2015
Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritisYoann Rombouts, Annemiek Willemze, Joyce J B C van Beers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2018
Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk IndividualsMarije K Verheul, Stefan Böhringer, Myrthe A M van Delft, et al.
The Review of Scientific Instruments|February 3, 2017
Inverse-collimated proton radiography for imaging thin materialsMatthew S Freeman, Jason Allison, Malcolm Andrews, et al.
Frontiers in Immunology|November 9, 2018
Complement Component C1q as Serum Biomarker to Detect Active TuberculosisRosalie Lubbers, Jayne S Sutherland, Delia Goletti, et al.
International Journal of Molecular Sciences|July 2, 2021
Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational StudyThijs W de Vos, Dian Winkelhorst, Hans J Baelde, et al.
Journal of Autoimmunity|June 30, 2015
Marked variability in clinical presentation and outcome of patients with C1q immunodeficiencyRosanne A van Schaarenburg, Lone Schejbel, Lennart Truedsson, et al.
Modern Rheumatology|April 15, 2021
Anti-carbamylated protein antibodies positivity and disease activity in Hispanic patients with established rheumatoid arthritis: An observational studyDavid Vega-Morales, Mario A Garza-Elizondo, Leendert A Trouw, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 31, 2020
HLA-B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid ArthritisCristina Regueiro, Desire Casares-Marfil, Karin Lundberg, et al.
Pageof 29